Zurück geht es hier Grüezi! Sie wurden auf finanzen.ch, unser Portal für Schweizer Anleger, weitergeleitet.  Zurück geht es hier.

WORLD Aktie 43373567 / JP3990210001

07.11.2025 20:00:17

XRP’s Price Doesn’t Match Its Growing Real-World Use, Study Finds

According to Bayberry Capital, XRP’s market price does not match its real-world role. The hedge fund firm argues the token is often judged like a speculative coin when it actually serves as plumbing for moving value between financial systems.The research compares the current stage of XRP to early internet infrastructure — quiet work laying the base while prices drift — and says many investors miss that deeper build-out. Ripple CEO Brad Garlinghouse has also stressed the token’s role across multiple settlement uses, reports show.Bayberry Capital Warns MispricingReports have disclosed that the investment house sees XRP as a liquidity tool, not just a tradable asset. It notes that institutional integrations, compliance work, and deep technical links take time to appear in prices.The firm believes the token’s recent price steadiness reflects growing backbone work, rather than lack of demand. Market observers are urged to look past headlines and volatility and weigh actual settlement activity.According To Onchain Data, Traders Are ShiftingBased on CryptoQuant data, open interest in BTC and ETH positions fell within the last 72 hours while XRP accumulation rose. That pattern is being read as traders rotating toward assets with clearer utility. The shift does not prove a long-term trend, but it does show changing flows in the short term.Binance Traders Pile into XRP as BTC & ETH Positions Unwind“Traders are using these slight dips to add positions, showing conviction that contrasts sharply with the fear gripping BTC and ETH markets.” – By @Crazzyblockk pic.twitter.com/QdXlsJCV2L— CryptoQuant.com (@cryptoquant_com) November 6, 2025Exchange Activity ShiftsLookonchain flagged a large move on Hyperliquid where a whale opened a short position worth over $20 million. The same actor moved $7 million in USDC into that DEX before placing the trade.At the same time, XRP’s price swung: after falling more than 13% to a low of $2.06 on Nov. 4, it climbed 6.27% the next day and reached $2.41. These opposing forces — fresh demand and a major short — are creating pressure around the current recovery attempt.Someone created a new wallet and deposited 7M $USDC to Hyperliquid, opening 20x short on both $BTC and $XRP.Positions:• 1,129 $BTC($116M)• 8,888,888 $XRP($20.35M)This guy seems to be a high-stakes gambler — he’s a Roobet and https://t.co/ZZPnpTmYqj user.… pic.twitter.com/GqWZaca4BC— Lookonchain (@lookonchain) November 6, 2025Ripple Partnerships Add Practical Use CasesReports show Ripple has expanded use of RLUSD after deals with Mastercard, WebBank, and Gemini. The company also raised $500 million at a $40 billion valuation, with backing that included Citadel Securities and affiliates of Fortress.Those moves are aimed at making it easier to settle credit-card transactions on the XRP Ledger using stablecoins, and they provide more pathways for real-world usage.Outlook And Market TensionBayberry Capital believes that slow-moving institutional adoption means the market underestimates what’s being built. Adoption, compliance checks, and systems integration do not happen overnight; they creep forward as partners sign deals and test flows.Featured image from Unsplash, chart from TradingViewWeiter zum vollständigen Artikel bei NewsBTC

Analysen zu WORLD CO. LTD. Registered Shs

  • Alle
  • Kaufen
  • Hold
  • Verkaufen
  • ?
Zu diesem Datensatz liegen uns leider keine Daten vor.
Eintrag hinzufügen

Erfolgreich hinzugefügt!. Zu Portfolio/Watchlist wechseln.

Es ist ein Fehler aufgetreten!

Kein Portfolio vorhanden. Bitte zusätzlich den Namen des neuen Portfolios angeben. Keine Watchlisten vorhanden. Bitte zusätzlich den Namen der neuen Watchlist angeben.

CHF
Hinzufügen

Abnehmspritzen – Ist der Hype vorbei? – mit Tim Schäfer

Ist der Hype um Abnehmspritzen wie bei Novo Nordisk und Eli Lilly vorbei – oder stehen wir erst am Anfang einer langfristigen Revolution im Gesundheitswesen? 💉📉

Im heutigen Gespräch mit Tim Schäfer @TimSchaeferMedia sprechen wir über die spannendsten Pharmawerte 2025. Neben den Abnehmspritzen blicken wir auch auf klassische Pharma-Giganten wie Pfizer, Johnson & Johnson, Roche, Novartis, AstraZeneca und GSK. Tim analysiert Übertreibungen, Rücksetzer und langfristige Chancen für Buy-and-Hold-Strategien – mit Fokus auf Dividende, KGV und Krisenresistenz.

💬 Was ist vom Abnehmtrend langfristig zu halten?
💬 Welche Pharma-Aktien sind aktuell unterbewertet?
💬 Was spricht für konservative Dividendenwerte im Gesundheitssektor?

👉🏽 https://bxplus.ch/wall-street-live-mit-tim-schaefer/

Abnehmspritzen – Ist der Hype vorbei? – Wall Street Live mit Tim Schäfer

Mini-Futures auf SMI

Typ Stop-Loss Hebel Symbol
Short 12’777.17 19.37 BWDSCU
Short 13’049.67 13.82 B7ZS2U
Short 13’525.87 8.98 B9GSAU
SMI-Kurs: 12’298.35 07.11.2025 17:31:28
Long 11’775.03 20.00 SIXBJU
Long 11’517.06 13.90 BBWS3U
Long 10’994.16 8.88 S2EBLU
Die Produktdokumentation, d.h. der Prospekt und das Basisinformationsblatt (BIB), sowie Informationen zu Chancen und Risiken, finden Sie unter: https://keyinvest-ch.ubs.com